ICON Public (ICLR) Projected to Post Earnings on Wednesday

ICON Public (NASDAQ:ICLR) is expected to release its earnings data after the market closes on Wednesday, February 19th. Analysts expect ICON Public to post earnings of $3.41 per share and revenue of $2.04 billion for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

ICON Public Stock Performance

ICLR stock opened at $186.21 on Monday. The company has a market cap of $15.36 billion, a P/E ratio of 20.76, a price-to-earnings-growth ratio of 1.78 and a beta of 1.19. ICON Public has a 1 year low of $181.51 and a 1 year high of $347.72. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.34 and a quick ratio of 1.34. The stock’s fifty day moving average price is $204.84 and its 200-day moving average price is $248.73.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on ICLR shares. TD Cowen decreased their target price on ICON Public from $369.00 to $285.00 and set a “buy” rating on the stock in a report on Friday, October 25th. Truist Financial decreased their target price on ICON Public from $284.00 to $262.00 and set a “buy” rating on the stock in a report on Thursday. The Goldman Sachs Group decreased their target price on ICON Public from $370.00 to $280.00 and set a “buy” rating on the stock in a report on Friday, October 25th. Leerink Partners reaffirmed an “outperform” rating and issued a $255.00 target price (down from $270.00) on shares of ICON Public in a report on Tuesday, November 19th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $263.00 target price on shares of ICON Public in a report on Wednesday, January 15th. Four analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $283.92.

About ICON Public

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.